Humana Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss increased by 487.5% to $94.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $82.00M to $94.00M. Over 3 years (FY 2022 to FY 2025), Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss shows a downward trend with a -61.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests rising interest rates or market volatility impacting the short-term valuation of the investment portfolio.
Represents the total accumulated unrealized losses on available-for-sale debt securities that have been in a continuous...
Standard disclosure for financial institutions under GAAP; peers typically report this in the investment securities note.
other_debt_securities_available_for_sale_continuous_unre_d33b47| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $270.00M | $98.00M | $103.00M | $28.00M | $68.00M | $66.00M | $9.00M | $178.00M | $82.00M | $53.00M | $19.00M | $16.00M | $94.00M |
| QoQ Change | — | -63.7% | +5.1% | -72.8% | +142.9% | -2.9% | -86.4% | >999% | -53.9% | -35.4% | -64.2% | -15.8% | +487.5% |
| YoY Change | — | — | — | -89.6% | -30.6% | -35.9% | — | +535.7% | +20.6% | -19.7% | +111.1% | -91.0% | +14.6% |